DECREASED MATERNAL SERUM HCG LEVELS WITH INCREASING GRAVIDITY AND PARITY

被引:21
作者
MOONEY, RA
ARVAN, DA
SALLER, DN
FRENCH, CA
PETERSON, CJ
机构
[1] UNIV ROCHESTER,MED CTR,DEPT PATHOL,ROCHESTER,NY 14642
[2] UNIV ROCHESTER,MED CTR,DEPT PEDIAT,ROCHESTER,NY 14642
[3] UNIV ROCHESTER,MED CTR,DEPT OBSTET & GYNECOL,ROCHESTER,NY 14642
关键词
D O I
10.1016/0029-7844(95)00308-E
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To investigate the preliminary observation that primigravid women have higher hCG multiples of the median (MoM) than multigravid women. Methods: An analysis of the effect of gravidity and parity on maternal serum alpha-fetoprotein (MSAFP) and hCG was performed using data from 20,009 consecutive singleton pregnancies of 15-20 weeks' gestation in a maternal serum screening program. Results: The human chorionic gonadotropin MoM for primigravid women was 0.1 MoM higher than for multigravid women. As parity or gravidity increased, maternal serum hCG decreased. The median hCG MoM for nulliparous women was 1.05, compared with 0.94 MoM for para 3 women. The decrease in hCG was similar at each gestational week from 15-20. In contrast, MSAFP and MSAFP MoM were unaffected by parity. Maternal age and race were potential contributing factors to the effect of parity. However, the decrease in hCG MoM with parity was observed within each 5-year increment of maternal age. Similarly, both black and non-black populations displayed decreases in hCG with parity, although black women had a consistently higher MoM in all matched sets. The decrease in hCG MoM with parity was also observed in 50 Down syndrome cases. Correcting patient data for parity resulted in the hCG MoM changing only 2.7% on average. The detection rate for the 50 Down syndrome cases would not have changed. Conclusion: The decrease in maternal serum hCG with increasing parity demonstrates that pregnancy history influences the level of maternal serum hCG. Further studies are needed to define the contributing factors, but the impact of parity on Down syndrome screening appears to be small.
引用
收藏
页码:900 / 905
页数:6
相关论文
共 18 条
[1]   ABNORMAL MATERNAL SERUM CHORIONIC-GONADOTROPIN LEVELS IN PREGNANCIES WITH FETAL CHROMOSOME-ABNORMALITIES [J].
BOGART, MH ;
PANDIAN, MR ;
JONES, OW .
PRENATAL DIAGNOSIS, 1987, 7 (09) :623-630
[2]   PROSPECTIVE EVALUATION OF MATERNAL SERUM HUMAN CHORIONIC-GONADOTROPIN LEVELS IN 3428 PREGNANCIES [J].
BOGART, MH ;
JONES, OW ;
FELDER, RA ;
BEST, RG ;
BRADLEY, L ;
BUTTS, W ;
CRANDALL, B ;
MACMAHON, W ;
WIANS, FH ;
LOEH, PV .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 165 (03) :663-667
[3]   2ND-TRIMESTER LEVELS OF MATERNAL URINARY GONADOTROPIN PEPTIDE IN DOWN-SYNDROME PREGNANCY [J].
CANICK, JA ;
KELLNER, LH ;
SALLER, DN ;
PALOMAKI, GE ;
WALKER, RP ;
OSATHANONDH, R .
PRENATAL DIAGNOSIS, 1995, 15 (08) :739-744
[4]   PRENATAL SCREENING FOR TRISOMY-18 IN THE 2ND TRIMESTER [J].
CANICK, JA ;
PALOMAKI, GE ;
OSATHANONDH, R .
PRENATAL DIAGNOSIS, 1990, 10 (08) :546-548
[5]   URINARY BETA-CORE HUMAN CHORIONIC-GONADOTROPIN - A NEW APPROACH TO DOWNS-SYNDROME SCREENING [J].
CUCKLE, HS ;
ILES, RK ;
CHARD, T .
PRENATAL DIAGNOSIS, 1994, 14 (10) :953-958
[6]   PRENATAL SCREENING FOR DOWNS-SYNDROME WITH USE OF MATERNAL SERUM MARKERS [J].
HADDOW, JE ;
PALOMAKI, GE ;
KNIGHT, GJ ;
WILLIAMS, J ;
PULKKINEN, A ;
CANICK, JA ;
SALLER, DN ;
BOWERS, GB .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (09) :588-593
[7]   USE OF MATERNAL SERUM ALPHA-FETOPROTEIN MEASUREMENTS TO SCREEN FOR DOWNS-SYNDROME [J].
KNIGHT, GJ ;
PALOMAKI, GE ;
HADDOW, JE .
CLINICAL OBSTETRICS AND GYNECOLOGY, 1988, 31 (02) :306-327
[8]   RACIAL-DIFFERENCES IN MATERNAL SERUM HUMAN CHORIONIC-GONADOTROPIN AND UNCONJUGATED ESTRIOL LEVELS [J].
KULCH, P ;
KEENER, S ;
MATSUMOTO, M ;
CRANDALL, BF .
PRENATAL DIAGNOSIS, 1993, 13 (03) :191-195
[9]  
MOONEY RA, 1994, OBSTET GYNECOL, V84, P298
[10]   HUMAN CHORIONIC-GONADOTROPIN LEVELS IN MATERNAL BLOOD IN LATE PREGNANCY - RELATION TO BIRTH-WEIGHT, SEX AND CONDITION OF THE INFANT AT BIRTH [J].
OBIEKWE, BC ;
CHARD, T .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1982, 89 (07) :543-546